Toni Choueiri
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Toni Choueiri
Jul 25, 2024, 13:04 |
Blog
Enrique Grande: Failure of Trials to Enhance Outcomes in mRCC Patients Re-challenged with Immunotherapy
Enrique Grande shared a post on X: "2 phase 3 trials have failed to improve…
Jul 22, 2024, 16:58 |
Blog
Toni Choueiri: Positive topline results for darolutamide in men with mHSPC
Toni Choueiri, shared a post on X: “Positive topline results for darolutamide from Phase III…
Jul 22, 2024, 13:38 |
Blog
Toni Choueiri: Excited for PMC2024 where over 7000 riders are focused on 1 mission
Toni Choueiri posted on X: "Last training ride before Pan-Mass Challenge ride on Team More…
Jul 20, 2024, 10:51 |
Blog
Toni Choueiri: TiNivo2 results are out
Toni Choueiri shared a post on X: ''TiNivo2 results are out - adding PD1 inhibitor…
Jul 15, 2024, 11:30 |
Blog
Neeraj Agarwal: Excellent talk by Michelle Hirsch on the pathology diagnosis of RCC variants
Neeraj Agarwal shared on X: "Surgical Pathology Toolbox and Technological Advances to Solve Kidney Cancer…
Jul 14, 2024, 05:55 |
Blog
RNA vaccines generate tumour specific immune responses with limited toxicity
Thomas Powles posted on X: "Personalised cancer vaccine trials have started in the adjuvant setting…
Jul 13, 2024, 20:46 |
Blog
Yüksel Ürün: Outstanding presentation at KCRS24 Rohit Mehra
Yüksel Ürün shared on X: "Outstanding presentation at KCRS 24 Rohit Mehra Role of Pathologist…
Jul 13, 2024, 12:22 |
Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Jul 12, 2024, 13:32 |
Societies
Insights from KCRS24 by Neeraj Agarwal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in…
Jul 12, 2024, 12:43 |
Blog
KidneyCAN - Insights from Toni Choueiri on Belzutifan monotherapy at KCRS24
KidneyCAN shared on LinkedIn: "KCRS24 Oral Abstract: Exciting insights from Toni Choueiri on the safety profile…
Jul 12, 2024, 11:26 |
Blog
KidneyCAN - Discover how the air we breathe can impact cancer at KCRS24
Toni Choueiri shared a post by KidneyCAN, on LinkedIn: "Our KidneyCAN meeting KCRS24 starts tomorrow with a…
Jul 10, 2024, 11:57 |
Blog
The 2024 Uromigos Cup
Uromigos formed in early 2017 as a group of friends attempting to provide balanced, scientific content…
Jul 8, 2024, 17:46 |
Blog
Toni Choueiri: Come and see the latest in kidney cancer translational, basic and clinical research
Toni Choueiri shared a post by KidneyCAN, on X, adding: ''Happening this week! Come and…
Jul 4, 2024, 10:51 |
Blog
Toni Choueiri: Some major changes for systemic therapies in the updated NCCN guidelines are in
Toni Choueiri shared a post on X: "Updated National Comprehensive Cancer Network (NCCN) guidelines (1.2025)…
Jul 1, 2024, 23:51 |
Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jun 28, 2024, 11:28 |
Societies
Keynote address by Myriam Chalabi at ESMOGI24
Toni Choueiri shared on X: "Keynote address at ESMOGI24 with superstar Myriam Chalabi- Immunotherapy for…
Jun 26, 2024, 15:32 |
Blog
Sleep Apnea is hepled by GLP-1 drugs
Toni Choueiri shared on X: "Just in NEJM: Sleep Apnea is also helped by the GLP-1…
Jun 26, 2024, 15:22 |
Insight
Results from the NIAGARA Phase III trial
AztraZeneca released the results of the NIAGARA phase III trial, where INFINZI (durvalumab) showed EFS…
Jun 26, 2024, 15:13 |
Blog
Toni Choueiri: Our new IMDC paper in ESMO Open led by Kosuke Takemura
Toni Choueiri shared a post by Kosuke Takemura, Staff Urologist at Ganken Hospital, on X: "Our new…
Jun 24, 2024, 07:29 |
Blog
Rahul Gosain: GU Malignancy Highlights from ASCO24 with Toni Choueiri
Rahul Gosain shared a post on LinkedIn: "GU (Genitourinary) Malignancy Highlights from ASCO24 (American Society…
Jun 23, 2024, 20:43 |
Blog
Toni Choueiri: Dr. Neil Shah's impressive multidisciplinary science-driven approach to immune-related toxicities
Toni Choueiri posted on X: "Thank you, Dr. Neil Shah, MSK Cancer Center for the…
Jun 19, 2024, 12:39 |
Blog
Toni Choueiri: Highly recommend this Master Class on Cancer
Toni Choueiri shared on X: "I very much enjoyed (between EURo2024 games) this dialogue between…
Jun 18, 2024, 04:53 |
Blog
Toni Choueiri: Thank you The ASCO Post for the interview during ASCO24
Toni Choueiri shared a post on LinkedIn: "Thank you The ASCO Post for the interview during…
Jun 16, 2024, 15:41 |
Blog
Toni Choueiri: We welcome our friend Stephen Boorjian to our GU seminars
Toni Choueiri recently shared a post on X: "We welcome our friend Stephen Boorjian to…
Jun 15, 2024, 05:42 |
Blog
Faisal Mahmood: Excited to share PathChat, a multimodal generative AI copilot
Toni Choueiri shared a post by Faisal Mahmood, Associate Professor at Harvard University, on X: "Very cool stuff…
Jun 11, 2024, 09:20 |
Blog
Toni Choueiri: Ocean side ride with Team More Cowbell in preparation for PMC2024
Toni Choueiri shared a post on LinkedIn: ''Beautiful ocean side ride with Team More Cowbell…
Jun 10, 2024, 15:00 |
Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
Jun 9, 2024, 02:45 |
Insight
Brian Rini: KIM-1 is a novel prognostic and predictive biomarker in RCC
Toni Choueiri shared a post by Brian Rini, Chief of Clinical Trials at Vanderbilt University, on X/Twitter:…
Jun 8, 2024, 02:16 |
Blog
Toni Choueiri: NICHE-2 by Myriam Chalabi published in NEJM
Toni Choueiri shared a post on X: , "NICHE-2 published…
Jun 7, 2024, 16:38 |
Blog
Aparna Sharma: Beginning the ASCO IDEA award mentorship at Dana-Farber Cancer Institute
Aparna Sharma, Assistant Professor in Department of Medical Oncology at All India Institute of Medical…
Jun 6, 2024, 09:52 |
Societies
Toni Choueiri: Dr. Robin Zon is all about her people
Toni Choueiri shared a post on X: "Dr. Robin Zon for 3 hours coming to…
Jun 6, 2024, 04:56 |
Societies
Zach Klaassen: Biomarker analyses in aRCC from Ph 3 CLEAR trial by Toni Choueiri
Zach Klaassen, Urology Oncologist at Georgia Cancer Center, shared a post on X: "Biomarker analyses…
Jun 6, 2024, 03:17 |
Societies
Robin Zon: Together we are stronger than cancer
Robin Zon, President-Elect of ASCO 2024-2025 and Chair of South Bend Medical Foundation, shared a…
Jun 6, 2024, 00:37 |
Blog
Toni Choueiri: We appreciate Robin Zon being "one of us"
Toni Choueiri shared on LinkedIn: . "We (soccer fans at…
Jun 5, 2024, 11:01 |
Insight
Toni Choueiri: Amazing ASCO24!
Toni Choueiri shared a post on LinkedIn: “Amazing ASCO24! Thank you Lynn Schuchter, Angela DeMichele, and…
Jun 5, 2024, 04:33 |
Blog
Toni Choueiri: Exciting advances in prostate cancer treatment at ASCO24!
Petros Grivas shared a post by Toni Choueiri, on X: "Promising data by Dr. Morris on novel…
Jun 5, 2024, 01:48 |
Societies
Toni Choueiri: Poster 269 by our super star Eddy Saad at ASCO24
Toni Choueiri shared a post on X: “Poster American Society of Clinical Oncology (ASCO24) 269 by…
Jun 4, 2024, 14:59 |
Societies
15 Posts From ASCO24 Day 4 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 3, 2024, 15:41 |
Blog
Yüksel Ürün: Honored to share a moment with two legends in GU oncology, Dr. Lawrence Einhorn and Dr. Toni Choueiri
Yüksel Ürün shared a post on X: "Honored to share a moment with two legends in…
Jun 1, 2024, 12:41 |
Blog
Sumanta K. Pal: Loved this interview with Toni Choueiri in the The ASCO Post
Sumanta K. Pal shared a post on X: "Loved this interview with Toni Choueiri in the…
Jun 1, 2024, 09:49 |
Insight
Jame Abraham: Thanks to the The ASCO Post for the write up!
Jame Abraham, Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic and…
May 28, 2024, 07:49 |
Insight
Tom Powles: Renal cancer highlights at ASCO24 - KIM1 biomarker data stands out
Toni Choueiri shared a post by Tom Powles, Director of Barts Cancer Center, on X and…
May 28, 2024, 01:03 |
Insight
Toni Choueiri: First Pan-Mass Challenge training ride
Toni Choueiri shared a post on LinkedIn: “First Pan-Mass Challenge training ride. Amazing scenery! Only 25…
May 27, 2024, 11:41 |
Blog
Rafeh Naqash: Looking forward to being part of this Timely session ASCO
Rafeh Naqash, Associate Professor and Director of Clinical Research at UT Southwestern Medical Center, shared on…
May 27, 2024, 04:18 |
Blog
Toni Choueiri: My Top* 10 pending LBAs
Toni Choueiri shared a post on LinkedIn: "Pending LBAs, my Top* 10." Source: Toni Choueiri/LinkedIn
May 26, 2024, 06:02 |
Insight
Toni Choueiri: The work of Eddy Saad, Eli Van Allen, Sasha Gusev being highlighted here at ASCO24
Toni Choueiri shared a post by Neeraj Agarwal on X/Twitter: "The work of Eddy Saad, Eli Van…
May 25, 2024, 14:20 |
Blog
Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC
Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on…
May 25, 2024, 04:57 |
Blog
Research efforts exploring IO rechallenge after prior ICI exposure to understand its potential in mRCC - ASCO
Toni Choueiri shared a post by ASCO on X/Twitter: "Thank you ASCO Daily News for the…
May 24, 2024, 19:29 |
Insight
Toni Choueiri: Make sure to attend this session on Celebrating, and Supporting IMGs in Oncology during ASCO24
Toni Choueiri shared a post on X: “Make sure to attend this session on Recognizing, Celebrating,…
May 24, 2024, 06:53 |
Insight
Daniel Stover: IMG representation at international oncology conferences
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
May 23, 2024, 06:36 |
Insight
María Natalia Gandur Quiroga: New insights on immunotherapy rechallenge in mRCC
María Natalia Gandur Quiroga shared on X: "New insights on immunotherapy rechallenge in mRCC! Key…
May 23, 2024, 00:35 |
Drugs
Toni Choueiri: The story of adaptive IO therapy in RCC
Toni Choueiri recently shared a post by Rana McKay, an Associate Professor of Medicine at…
May 22, 2024, 00:33 |
Blog
Toni Choueiri: Announcement of new Felix Feng Endowed ASCO YIA by President-Elect Eric Small
Toni Choueiri shared a post on LinkedIn: ''Announcement of new Felix Feng Endowed American Society of…
May 20, 2024, 14:22 |
Blog
Nancy Lin: So fitting for a YIA to be dedicated to him and moving to see such an outpouring of support
Nancy Lin, Associate Chief of Division of Breast Oncology at Susan F. Smith Center for…
May 15, 2024, 10:04 |
Blog
Quoc-Dien Trinh: I had the immense honor of delivering the Journal of Urology plenary lecture at the American Urological Association annual meeting
Toni Choueiri shared a post by Quoc-Dien Trinh, Chief of Urology at Brigham and Women’s Faulkner Hospital,…
May 9, 2024, 15:09 |
Blog
Toni Choueiri: Life is too short to be angry!
Toni Choueiri shared a post on X: "A randomized controlled experimental study from Columbia University Irving…
May 7, 2024, 23:15 |
Blog
Chadi Nabhan: Only at the HOPLive24 you could spot Vincent Rajkumar playing guitar while Aaron Goodman attempting to sing
Vivek Subbiah shared the following post by Chadi Nabhan, Medical Director of The University of Chicago…
May 7, 2024, 10:25 |
Career
Tom Powles has been named in TIME100 Health - Barts and The London School of Medicine and Dentistry
Toni Choueiri shared a post by Barts and The London School of Medicine and Dentistry…
May 1, 2024, 16:28 |
Career
Toni Choueiri: The Dana-Farber Lank Center for Genitourinary Oncology is hiring again
Toni Choueiri shared on X: “Well, the Dana-Farber Lank Center for Genitourinary Oncology is hiring…
Apr 29, 2024, 15:54 |
Insight
Toni Choueiri: Big news to start the day: DESTINY-Breast06 Phase III trial
Toni Choueiri shared on X: "Big news to start the day: DESTINY-Breast06 Phase III trial…
Apr 27, 2024, 09:28 |
Positive
Stephanie Berg: The power of the cooperative groups!
Toni Choueiri shared a post by Stephanie Berg, Medical oncologist at Lank Center for Genitourinary…
Apr 26, 2024, 11:57 |
Blog
Myriam Chalabi: What happens in Zurich….goes to ESMO25
Myriam Chalabi shared on X/Twitter: ''What happens in Zurich….goes to ESMO25! Fantastic meeting and discussions…
Apr 26, 2024, 11:10 |
Blog
Vivek Subbiah: The world of oncology converges in Zurich, Switzerland!
Vivek Subbiah posted on X/Twitter: ''The world of oncology converges in Zurich, Switzerland! Such an…
Apr 24, 2024, 12:07 |
Blog
Vivek Subbiah: One mission = Eradicate cancer
Vivek Subbiah shared on Twitter/X: "One of the greatest advantages of in person scientific meetings is…
Apr 23, 2024, 08:06 |
Blog
Vivek Subbiah: We’ve been to the moon, now to mars and beyond to Eradicate Cancer
Vivek Subbiah posted on X/Twitter: "We’ve been to the moon, now to mars and beyond…
Apr 22, 2024, 19:40 |
Blog
Apply to the King Hussein Cancer Research Award
Toni Choueiri shared a post by King Hussein Cancer Foundation and Center on LinkedIn: "Thank you King Hussein…
Apr 21, 2024, 08:54 |
Insight
Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe
Rana McKay won the 2024 Christopher G. Wood Rising Star Award at IKCS Europe, which…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 19, 2024, 08:07 |
Insight
Toni Choueiri: An inspiration to all trainees
Toni Choueiri, shared a post by Ziad Bakouny, Hematology/Oncology fellow at Memorial Sloan Kettering Cancer Center,…
Apr 17, 2024, 10:09 |
Positive
Yaniss B.: The 3rd edition of the Transatlantic Exchanges in Oncology was a huge success!
Yaniss B, Valorisation Officer at Gustave Roussy Transfert shared on X: “The 3rd edition of the…
Apr 16, 2024, 13:22 |
Blog
Toni Choueiri: And that is a wrap for the Transatlantic conference between Dana-Farber, Gustave Roussy
Toni Choueiri shared on their X/Twitter: ''And that is a wrap for the Transatlantic conference…
Apr 16, 2024, 01:37 |
Blog
Did you know Robert Haddad and Toni Choueiri had a competitive streak? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Did you know Robert Haddad and Toni…
Apr 14, 2024, 07:20 |
Societies
Daniel Castellano: The ASCO24 football tournament is back again this year
Daniel Castellano, Medical Oncologist at University Hospital October 12, shared on X/Twitter: ''The most funky,…
Apr 13, 2024, 10:28 |
Opinion
Toni Choueiri: Wonderful pickleball game to benefit Dana-Farber Cancer Institute and The Jimmy Fund
Toni Choueiri shared a post on LinkedIn: "Thank you Rob Gronkowski and Julian Edelman for…
Apr 11, 2024, 17:23 |
Blog
Toni Choueiri: Back in business - The SOCCER ASCO game is back during ASCO24
Toni Choueiri recently shared a post on X: "Back in business: The SOCCER ASCO game…
Apr 10, 2024, 05:06 |
Insight
Toni Choueiri: The Renee Saliby kidney cancer biomarker paper in Cancer Cell is online with a detailed tweetorial
Toni Choueiri shared a post by Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber…
Apr 8, 2024, 22:02 |
Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Apr 4, 2024, 14:05 |
Insight
Toni Choueiri: More evidence that ICI after ICI may not be effective
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Apr 4, 2024, 13:47 |
Insight
Sumanta K. Pal: Excellent real world confirmation of our observations in CONTACT03
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
Apr 1, 2024, 19:03 |
Blog
Top Influencers in GU Ocology by LARVOL
LARVOL shared on their X/Twitter page: "Delving into GU Oncology, we’re thrilled to spotlight the…
Mar 26, 2024, 05:00 |
Blog
Toni Choueiri: Major Victory for kidney cancer research Funding! 50 million Dollars Awarded!
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Mar 13, 2024, 16:19 |
Blog
Toni Choueiri: The April ASCO Plenary Series are here
Toni Choueiri shared the following post on X: "The April ASCO Plenary Series are here:…
Mar 1, 2024, 18:08 |
Insight
Shankar Siva: For Kidney Cancer Awareness month The Lancet Oncology has a 50-day full link to TROG Cancer Research FASTRACK II
Quoting Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, on X/Twitter: ''For Kidney…
Feb 24, 2024, 16:50 |
Blog
Toni Choueiri: New insights from the JAVELIN Renal 101 trial in RCC in Cancer Discovery
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center for…
Feb 22, 2024, 10:58 |
Blog
Toni Choueiri: The 3rd transatlantic exchanges between Dana-Farber Cancer Institute and Gustave Roussy happening on April 12
Toni Choueiri, Senior Executive and Chief of Genitourinary Cancers at Dana-Farber Cancer Institute, shared a…
Feb 19, 2024, 14:16 |
Blog
The inaugural Oncology Symposium at Arab Health was a great success - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute made the following on LinkedIn: "We are pleased to share that the…
Feb 1, 2024, 17:14 |
Insight
Sumanta K. Pal: She has developed what I think should be called the 'Bergerot QOL Index ' for kidney cancer
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
Jan 31, 2024, 14:14 |
Blog
Elad Sharon: The hottest new ICI BOTENSILIMAB in Kidney Cancer
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Michael Serzan, Genitourinary…
Jan 30, 2024, 16:28 |
Blog
Toni Choueiri: OS benefit in adjuvant Renal Cancer is finally here
Toni Choueiri, Medical Doctor and Professor at Dana-Farber Cancer Institute, recently posted on LinkedIn: "51…
Jan 29, 2024, 19:22 |
Blog
Toni Choueiri: This is humility at best
Toni Choueiri shared on LinkedIn: "The most iconic living oncologist (Larry Einhorn) who cured Testis Cancer,…
Jan 29, 2024, 17:43 |
Insight
Minas Economides: First positive OS trial in adjuvant RCC
Minas Economides, GU Medical Oncologist and Assistant Professor of Medicine at NYU Langone Health, shared…
Jan 27, 2024, 17:17 |
Societies
ASCO GU 2024 – New insights in clear cell renal cancer (RCC) – Adjuvant perspectives
By Marcos Franca During the morning in ASCO GU 2024 meeting, in San Francisco –…
Jan 14, 2024, 17:54 |
Insight
Toni Choueiri: The February ASCO Plenary Series are here
Toni Choueiri posted on X/Twitter: "The February ASCO Plenary Series are here: Why??? Well...'Because Science can't…
Jan 9, 2024, 11:14 |
Insight
Sharlene Gill: Very informative and impressive compilation
Sharlene Gill shared on X/Twitter: "Toni Choueiri - very informative and impressive compilation: exciting to see…
Jan 1, 2024, 18:39 |
Blog
Chandler Park: He is extremely caring and loyal
Chandler Park, Kentucky Physician Representative of ASCO State Executive Council, shared a post on LinkedIn:…
Dec 31, 2023, 17:01 |
Insight
Toni Choueiri: MUST READ piece by Siddhartha Mukherjee on the causes of cancer
Toni Choueiri shared on X/Twitter: "MUST READ piece The New Yorker by Siddhartha Mukherjee on…
Dec 31, 2023, 06:19 |
Blog
TOP 10 GU Oncology clinical papers/published trials by 2023 by Toni Choueiri
Toni Choueiri shared on LinkedIn: “It is this time of the year again: TOP 10 GU…
Dec 24, 2023, 18:54 |
Drugs
Laurie Glimcher: Belzutifan is approved by the FDA
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: "Exciting news that…
Dec 18, 2023, 21:06 |
Insight
Toni Choueiri: A new option for our Kidney Cancer patients!
Toni Choueiri shared on LinkedIn: "JUST IN: FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell…
Nov 25, 2023, 17:16 |
Blog
Toni Choueiri: Looking forward to speak at this SABCS23 session about biomarkers of immunotherapy toxicity
Toni Choueiri, Director of the Lank Center for Genitourinary Cancers and the Medical Director of…
1
2
All:
117
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube